The Johnstone Lab

Peter Mac's @JohnstoneRicky and @MonashUni researchers have designed a single drug that delivers a lethal ‘one-two’ punch to several types of #bloodcancer in preclinical studies and could lead to improved treatments. Read the full story: petermac.org/about-us/news-…

Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma | PNAS pnas.org/doi/abs/10.107… Proud of our collaborative effort. Great working @SCSMonash with @JohnstoneRicky and @MIPS_Australia. Thanks to @NFMRI for the support.

CDK9 is an important target in NHL. In heavily-pretreated DLBCL pts including many post CAR-T, ORR/CR 50%/20% and some are durable. Excited to share clinical data on the molecule our lab and Australian colleagues helped advance into trials #ICML17 @JohnstoneRicky @DrAnasYounes

WEHI's @Stephintje is one of three Australian researchers to receive an $8m Fellowship from @SnowMedical. He will use the Fellowship to study the cell’s messenger factory, RNAPII, to find new treatment options for cancers such as leukaemia. wehi.edu.au/news/8m-snow-f…

Congratulations to our 2022 CSL Centenary Fellows: Associate Professor Daniel Watterson, @UQ_News @DWatterson_ and Dr Stephin Vervoort @WEHI_research and @PeterMacCC @Stephintje. bit.ly/3mfE3yo

Peter Mac provides a world-class research education program at a leading Australian cancer research institution for students from Australian and international universities. Come to our Vitual Research Student Open Day to find out how you can get involved: bit.ly/3mWPwU6

In the latest issue! The balance between kinase and phosphatase activity provides a control point for gene expression that can be exploited to inhibit tumorigenesis #cancerresearch @JohnstoneRicky @PeterMacRes @JohnstoneLab @PeterMacCC bit.ly/3vbPJmT